The Oxford Handbook of Palliative Care returns for a third edition, maintaining the concise yet comprehensive format suited to the busy practitioner for quick access to key information, and fully updated to reflect changes in the palliative care landscape.
Featuring an increased emphasis on non-malignant diseases such as dementia, this authoritative text combines evidence-based care with the bedside experience of experienced palliative care professionals to give the reader a complete overview of the physical, emotional, and spiritual aspects of care for the end-of-life patient. Symptom management is covered in detail, with updated formulary tables and syringe driver protocols, and a new chapter on international perspectives to broaden the reader's perception of methods for delivering end-of-life care.
The third edition of the Oxford Handbook of Palliative Care is the essential companion for all of those working with adults, children, and families with palliative care needs, in both hospital and community settings.
A concise, practical guide to the physical, emotional, and spiritual aspects of palliative care
Practical issues are explained by active practitioners to combine evidence-based care and bedside experience
Includes the latest guidelines and management options for delivering end-of-life care
New to this Edition:
Includes new sections on international access to palliative care, Advance Care Planning, and palliative care for non-malignant diseases
Fully updated, including guidelines, drug formularies, and paediatric drugs
Table of Contents
1: Ethical issues and the person in the patient
2: Communication in palliative care
3: Research in palliative care
4: Quality of life
5: Principles of drug use in palliative care
6: Oncology and palliative care
7: Palliative care and haematology
8: Pain management
9: Gastrointestinal symptoms
10: Respiratory symptoms
11: Genitourinary symptoms
12: Skin problems in palliative care
13: Neurological problems in advanced cancer
14: Palliation of head and neck cancer
15: Endocrine and metabolic complications of advanced cancer
16: Paediatrics
17: Heart failure
18: Renal failure
19: HIV and palliative care
20: Dementia and frailty
21: Palliative care in non-malignant neurological disease
22: Psychiatric symptoms in palliative care
23: Spiritual care
24: The contribution to palliative care of allied health professions
25: Complementary and alternative medicine
26: Population based end of life care
27: Hospital liaison
28: Palliative and end of life care for people with learning disabilities
29: Emergencies
30: Terminal phase
31: Bereavement
32: Self care for health professionals
33: Access to palliative care - international perspectives
34: Miscellaneous
The following correction has been made online and will be included in the first reprint. Readers can get in touch with us directly using the contact details on the back of the book or at our online form via the address below with questions or comments: https://global.oup.com/academic/category/medicine-and-health
Chapter 5. Page 109
The dose for Hyoscine butylbromide sc has been amended in line with NICE guidance (https://bnf.nice.org.uk/drug/hyoscine-butylbromide.html): '20-120 mg 4 hourly' has been corrected to '20-80mg 4 hourly'.
